CVE-2023-31167: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Schweitzer Eng

Q: How do I fix CVE-2023-31167?

sel-5036 acselerator bay screen builder: upgrade to 1.0.49152.778. Exact commands for each OS are on this page.

Q: Is CVE-2023-31167 being exploited?

CVE-2023-31167 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.

Q: What does CVE-2023-31167 affect?

CVE-2023-31167 affects sel-5036 acselerator bay screen builder. Severity is medium (CVSS 5.0). Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Schweitzer Engineering Laboratories SEL-5036 acSELerator Bay Screen Builder Software on Windows allows Relative Path Traversal. SEL acSELerat

Q: How urgent is CVE-2023-31167?

Priority 27/100. No elevated risk signals yet.

Routine

MEDIUM 5.0UPGRADE

CVE-2023-31167 is a medium-severity flaw (CVSS 5.0) affecting sel-5036 acselerator bay screen builder. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Schweitzer Engineering Laboratories SEL-5036 acSELerator Bay Screen Builder Software on Windows allows Relative Path Traversal. SEL acSELerator Bay Screen Builder software is distributed by SEL-5033 SEL acSELerator RTAC, SEL-5030 Quickset, and SEL Compass. CVE-2023-31167 and was patched in the acSELerator Bay Screen Builder release available on 2023

Why this priority

No elevated risk signals yet

A fixed release or distro patch exists.

Risk facts

CVSS score	5.0 (Medium)
Attack vector	Local
Attack complexity	Low
Privileges needed	Low
User interaction	Required
EPSS exploit chance	0.4% (top 63%)
CISA exploited list	No
Weakness	CWE-22
Published	2023-08-31
Last modified	2026-06-17

Publisher (CNA): Schweitzer Engineering Laboratories, Inc. · Vendor: selinc

Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score

Am I affected?

Timeline

2023-08-31 16:15 UTCPublished CVE record published
2026-06-17 05:56 UTCUpdated Record last modified

selinc sel-5036 acselerator bay screen builder UPGRADE

Affected: < 1.0.49152.778

Fixed in: 1.0.49152.778

Safe to downgrade to: no unaffected older release

1. Check installed version

apt-cache policy sel-5036-acselerator-bay-screen-builder || rpm -q sel-5036-acselerator-bay-screen-builder || sel-5036-acselerator-bay-screen-builder --version

2. UPGRADE to 1.0.49152.778 (Debian / Ubuntu)

sudo apt update && sudo apt install --only-upgrade sel-5036-acselerator-bay-screen-builder

2. UPGRADE (RHEL / Amazon Linux / Fedora)

sudo dnf upgrade sel-5036-acselerator-bay-screen-builder

Note

Distros often backport fixes without changing the version number. Confirm with the distro advisory or changelog.

Verify at the official source NVD · CVE Program · Report a problem with this page
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.

Quick answers

How do I fix CVE-2023-31167?

sel-5036 acselerator bay screen builder: upgrade to 1.0.49152.778. Exact commands for each OS are on this page.

Is CVE-2023-31167 being exploited?

CVE-2023-31167 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.

What does CVE-2023-31167 affect?

CVE-2023-31167 affects sel-5036 acselerator bay screen builder. Severity is medium (CVSS 5.0). Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Schweitzer Engineering Laboratories SEL-5036 acSELerator Bay Screen Builder Software on Windows allows Relative Path Traversal. SEL acSELerat

How urgent is CVE-2023-31167?

Priority 27/100. No elevated risk signals yet.

Software pages

Windows vulnerabilities

References

← Back to latest CVEs